Long-Term Results of NRG Oncology/RTOG 0321 A Phase II Trial of Combined High Dose Rate Brachytherapy and External Beam Radiotherapy for Adenocarcinoma of the Prostate

The primary goal of this study is to estimate the rate of treatment related late GI/GU toxicity. It was originally reported in 2010. This is a report of long-term patient outcome following treatment with external beam radiation therapy (EBRT) and prostate high dose rate (HDR) brachytherapy from a prospective phase II, multi-institutional collaborative trial conducted by NRG Oncology/RTOG.

Source: Brachytherapy - April 30, 2019 Category: Cancer & Oncology Authors: I-Chow Joe Hsu, Joseph Rodgers, Katsuto Shinohara, James Purdy, Jeff Michalski, Mack Roach, Eric Vigneault, Robert Ivker, Rodger Pryzant, Michael Kuettel, Daniel Taussky, Gary Gustafson, Adam Raben, Howard Sandler Source Type: research